US SEC Filings Daily Market Digest — April 15, 2026

15-04-2026

M&T Bank Corporation reported Q1 2026 net income of $664 million ($4.13 diluted EPS), up 14% YoY from $584 million ($3.32 EPS) but down 13% QoQ from $759 million ($4.67 EPS), with net interest income at $1,752 million, down 2% QoQ but up 3% YoY alongside NIM expansion to 3.71%. Average loans grew 1% QoQ and 3% YoY to $138,423 million, driven by commercial and industrial loans, though partially offset by declines in commercial real estate (-3% QoQ, -11% YoY) and consumer loans. Noninterest expense rose 4% QoQ to $1,438 million, pushing the efficiency ratio to 58.3% from 55.1%, while the company repurchased 5.5 million shares for $1.25 billion.

• ·Nonaccrual loans declined 1% QoQ to $1,240 million and 19% YoY.
• ·Provision for credit losses increased 12% QoQ to $140 million.
• ·Average interest-bearing deposits at banks fell 10% QoQ and 18% YoY to $16,231 million.
• ·Short-term borrowings rose 176% QoQ to $5,695 million.

15-04-2026

Structure Therapeutics Inc. (NASDAQ: GPCR) appointed Matthew Lang, J.D. as Chief Operating Officer and General Counsel, leveraging his over 15 years of executive experience from Metsera, Lyell Immunopharma, Myovant Sciences, and Gilead Sciences. CEO Raymond Stevens emphasized Lang's expertise in growth, strategic transactions, and commercialization, critical for advancing aleniglipron into Phase 3 trials. The appointment strengthens the leadership team amid a competitive obesity pipeline development.

• ·Announcement date: April 14, 2026
• ·Mr. Lang managed Myovant’s European operations in Basel, Switzerland
• ·Company pipeline targets GPCR for obesity and metabolic diseases via structure-based drug discovery platform

15-04-2026

Mission Produce, Inc. issued a Form 425 supplement to the Joint Proxy Statement/Prospectus for its merger with Calavo Growers, Inc., clarifying that potential one-time Mexican transfer taxes payable post-closing will not exceed $5 million, addressing a previously disclosed risk of significant unanticipated expenses. This disclosure supersedes prior information and is based on Mission Produce's current analysis. No other financial metrics, declines, or flat performances are mentioned.

• ·Merger Agreement entered into on January 14, 2026
• ·Supplements Registration Statement on Form S-4 (File No. 333-294128)
• ·Taxes relate to post-closing transfer under Mexican law

15-04-2026

Allbirds, Inc. has filed a preliminary proxy statement for a Special Meeting seeking stockholder approval of an Asset Sale with a $39.0 million purchase price, adoption of a Plan of Dissolution and Distribution, and a Charter Amendment to eliminate its public benefit corporation status. Net proceeds are uncertain and expected to be lower after transaction expenses, taxes, and potential escrow claims, with significant risks highlighted including deal failure, litigation, employee distractions, and reduced distributions. No historical financial performance metrics or period comparisons are provided.

• ·Fiscal year ended December 31, 2025; Annual Report on Form 10-K filed with SEC on March 30, 2026
• ·Final voting results for Special Meeting to be published via Form 8-K within four business days after results known
• ·Proxy materials available on www.sec.gov and company investor relations website

15-04-2026

Chunghwa Telecom reported total revenues of NT$236.1 billion in 2025, up 2.7% YoY from NT$230.0 billion in 2024 and 5.9% from NT$223.2 billion in 2023, driven by growth in Others (+27.7% YoY) and Enterprise Business (+2.4% YoY), while Consumer Business grew modestly (+2.4% YoY) but declined slightly as a percentage of total to 60.7%. Consolidated net income rose 5.2% YoY to NT$40.5 billion, with operating income up 3.6% to NT$48.6 billion; however, International Business revenues fell 4.0% YoY to NT$9.5 billion, net cash from operations dipped 2.1% to NT$77.5 billion, and operating margin remained relatively flat around 20.6%. Capital expenditures declined to NT$27.7 billion in 2025, with guidance for NT$31.9 billion in 2026, and dividends increased to NT$5.2000 per share (total NT$40.3 billion).

• ·Capex guidance for 2026: NT$31.9 billion total, with Mobile 24% (NT$7.7B) and Others 76% (NT$24.2B).
• ·Cash and cash equivalents at end of 2025: NT$36.9 billion.
• ·Noncontrolling interests in net income 2025: NT$1.8 billion (up from NT$1.3B in 2024).

15-04-2026

Snap Inc announced organizational changes impacting approximately 1,000 team members, or 16% of full-time employees, and closing over 300 open roles, as part of a restructuring to prioritize long-term value. These changes are expected to reduce the annualized cost base by more than $500 million by the second half of 2026, supporting a path to net-income profitability. While painful in the short term, the moves leverage AI advancements to enhance efficiency in areas like Snapchat+ and Snap Lite.

• ·U.S. departing employees receive four months of severance, healthcare coverage, equity vesting, and career transition support.
• ·Non-U.S. locations to follow local processes with comparable support.
• ·North America team instructed to work from home on announcement day.

15-04-2026

15-04-2026

LSB Industries, Inc. (LXU) filed a DEFA14A Definitive Additional Materials proxy statement with the SEC on April 15, 2026. The filing relates to the period from January 1, 2025, to December 31, 2025, and confirms no filing fee was required. No substantive financial or operational updates are provided in the document.

15-04-2026

News Corporation disclosed information provided to the Australian Securities Exchange (ASX) on April 14, 2026, regarding its ongoing $1 billion stock repurchase program for Class A and Class B common stock, as required under ASX rules for daily transaction reporting if any occur. The details are attached as Exhibits 99.1 and 99.2 to the 8-K filing. No specific repurchase transactions are detailed in the filing itself.

15-04-2026

Motive Wealth Advisors filed its Form 13F-HR on April 15, 2026, disclosing 92 equity holdings as of March 31, 2026, consisting primarily of sole discretionary positions in large-cap stocks and ETFs. Notable positions include Schwab Strategic Trust Broad Market ETF (474,496 shares), Vanguard Tax-Managed Funds Van FTSE Dev Mkt (346,246 shares), and NVIDIA Corporation (26,181 shares), alongside other significant holdings in Apple Inc. (15,937 shares) and Amazon.com Inc. (10,653 shares). No market values or changes from prior periods are reported in the filing.

• ·Report period end date: March 31, 2026
• ·All positions reported as sole discretionary ownership with no options or shared voting/discretion
• ·Contact: Aryn Sands, Agent, Reno NV

15-04-2026

Eightco Holdings Inc. reported a sharp revenue decline of 16.76% YoY to $32,981,126 for FY 2025 from $39,621,272 in FY 2024, with gross profit dropping 91.07% to $534,329 amid higher SG&A expenses up 87.27% and a new $33,854,230 impairment charge. The company posted a massive net loss of $262,013,060, driven by a $202,299,922 decline in fair value of digital assets, contrasting with a small net income of $708,527 in 2024; however, total assets surged to $250,193,124 from $50,848,355, bolstered by $175,901,645 in digital assets and $58,501,108 in cash from $448M in financing activities including PIPE and ATM equity raises.

• ·Cash used in operating activities increased to $10,973,526 in FY 2025 from $6,637,101 in FY 2024.
• ·Operating loss widened to $57,214,549 in FY 2025 from $8,192,559 in FY 2024.
• ·Convertible notes payable eliminated in 2025 (zero from $21M total in 2024).
• ·Common shares outstanding increased dramatically to 205,629,592 from 2,479,363 due to PIPE ($251M) and ATM ($187M) issuances.
• ·Non-controlling interest stable at ($414,514).

15-04-2026

FortuneX Acquisition Corp, a Cayman Islands blank check company with Sponsor and executives tied to PRC, filed S-1 registration for a $75,000,000 IPO of 7,500,000 units at $10.00 each (up to $86,250,000 with over-allotment), with $250,000 upfront underwriting discounts and $3,750,000 deferred fee upon business combination. Net proceeds of $74,750,000 will be placed in trust at $10.00 per unit. However, the filing highlights substantial risks from potential PRC target acquisition, including regulatory uncertainties, HFCAA delisting risks, and dilution to public shareholders ranging from $4.07 to $10.79 per share across redemption scenarios.

• ·Pro forma net tangible book value per share as of March 31, 2026: ranges from $5.93 (25% redemptions with over-allotment) to -$0.79 (100% redemptions with over-allotment)
• ·Auditor Simon & Edward LLP is PCAOB-inspected; no current HFCAA impact but risks if PRC/HK operations post-combination
• ·Filing date April 14-15, 2026; symbols FXAC and FXACW on Nasdaq post-separate trading

15-04-2026

SONIM Technologies Inc. reported zero net revenues and zero gross profit for both fiscal years 2025 and 2024, reflecting flat performance with no revenue generation. Operating expenses rose to $5,406 from $3,100, driven by higher general and administrative costs, resulting in a widened net loss of $7,955 compared to $2,883 in 2024. The filing highlights ongoing risks including cryptocurrency volatility, regulatory changes, lack of profitability, and dependence on third-party contractors.

• ·General and administrative expenses: $5,406 in 2025 vs. $3,100 in 2024.
• ·Other income (expense), net: ($902) in 2025 vs. $246 in 2024.
• ·Loss on extinguishment of debt: $161 in 2025 (none in 2024).

15-04-2026

15-04-2026

TeraWulf Inc. priced its upsized public common stock offering at 47,400,000 shares for $19.00 per share, yielding gross proceeds of approximately $900 million, up from an original $800 million target. The offering is expected to close on April 16, 2026, subject to customary conditions. Underwriters received a 30-day option to purchase up to an additional 7,110,000 shares at the offering price less discounts.

• ·Offering announced and priced on April 14, 2026
• ·Underwriters' option valid for 30 days from pricing

15-04-2026

15-04-2026

FG Merger II Corp. (FGMC) filed Amendment No. 3 to its Form S-4 registration statement on April 14, 2026, advancing its business combination with BOXABL Inc. via a Nevada-to-Texas conversion and two-step merger process under a Merger Agreement dated August 5, 2025 (as amended). The deal provides for aggregate merger consideration based on $3,500,000,000 at $10 per share, with BOXABL common stock converting via the Common Exchange Ratio and preferred stock via the Preferred Exchange Ratio; FGMC will rename to BOXABL Inc. post-closing. The prospectus covers 247,331,061 shares of common stock and 102,668,939 shares of preferred stock, among others, with no operational financial metrics or period comparisons disclosed.

• ·Merger Agreement dated August 5, 2025, amended November 3, 2025 and April 6, 2026.
• ·Special meetings of FGMC and BOXABL stockholders to approve the Business Combination.
• ·No fractional shares issued; rounded up with pro rata reduction to Paolo Tiramani and Galiano Tiramani affiliates.
• ·FGMC classified as smaller reporting company and emerging growth company.

15-04-2026

CV Sciences, Inc. will hold its virtual annual stockholder meeting on June 2, 2026, to elect three directors, approve an amendment authorizing a discretionary reverse stock split of common stock at a ratio between 1-for-10 and 1-for-800 (to be determined by the Board before May 30, 2029), and ratify Haskell & White LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is April 6, 2026, with 193,458,420 shares of common stock outstanding held by approximately 41 stockholders of record. The Board recommends voting FOR all proposals.

• ·Meeting is completely virtual; stockholders cannot vote through the platform but must use proxy methods until polls close
• ·Proxy materials available electronically via Notice and Access; mailed around April 16, 2026
• ·Principal executive offices: 9530 Padgett Street, Suite 107, San Diego, California 92126

15-04-2026

RetinalGenix Technologies Inc. (RTGN) filed its 10-K annual report on April 15, 2026, detailing extensive risk factors across financial, operational, regulatory, and market domains. The company highlights no revenue from commercial sales, ongoing net losses, substantial doubt about its ability to continue as a going concern, dependency on future capital raises that may dilute shareholders, and uncertainties in product development, regulatory approval, manufacturing, and commercialization. Additional risks include product liability, competition, IT dependencies, key personnel retention, stock volatility, and anti-takeover provisions.

15-04-2026

Exchange Traded Concepts, LLC filed its 13F-HR combination report on April 15, 2026, disclosing institutional equity holdings as of March 31, 2026, across multiple managers including Saba Capital Management, L.P. and Miller Value Partners, LLC. Key positions include Amazon.com Inc. at $188745937, Alphabet Inc. CAP STK CL A at $137218168, and Alphabet Inc. CAP STK CL C at $38387031, with no prior period data provided for comparisons. The portfolio spans over 100 securities with no reported changes or performance metrics.

• ·Filing includes holdings in over 100 securities such as AAR CORP (value 21345), ADMA BIOLOGICS INC (31508), and Abbott Laboratories (754316 OTR 1, 4220045 OTR 14)
• ·Report period end date: March 31, 2026
• ·Certified by N Dennis Lowenfels on April 14, 2026

15-04-2026

Avondale Wealth Management filed its 13F-HR on April 15, 2026, disclosing 71 equity holdings as of March 31, 2026, with a total market value of $203460351. The portfolio is heavily weighted toward ETFs, with the largest position in iShares Core S&P 500 ETF at $37212213, followed by iShares Core S&P Mid-Cap ETF at $20055794 and Invesco QQQ Trust at $19064689. Other notable holdings include American Century U.S. Small Cap Value ETF ($17370796) and Dimensional Emerging Markets Core Equity Management ETF ($14149508).

• ·Filing covers period ending March 31, 2026
• ·All holdings reported as sole discretionary
• ·Portfolio includes significant allocations to Bitcoin ETFs (e.g., ARK 21Shares Bitcoin ETF $204078, iShares Bitcoin Trust $537880) and energy/oil funds

15-04-2026

Koesten, Hirschmann & Crabtree, INC. filed its 13F-HR report disclosing 41 equity positions with a total market value of $205247059 as of March 31, 2026. The portfolio is dominated by ETFs, including top holdings such as Schwab Strategic TR Fundamental US L (47477395), Schwab Strategic TR Intl Eqty ETF (23823595), Vanguard Index Fds Large Cap ETF (36308306), and Schwab Strategic TR US Lrg Cap ETF (20658353), alongside smaller positions in individual stocks like Apple Inc (2216253) and Microsoft Corp (388947). No changes, options, or other voting powers beyond sole discretionary are reported.

• ·Report filed April 15, 2026; period end March 31, 2026
• ·All 41 positions held with sole voting and sole discretionary power (SH SOLE)
• ·No put/call options or other managers reported for any position

15-04-2026

Innventure, Inc. issued a press release on April 14, 2026, announcing it will host an operating company CEO call on April 27, 2026, at 5:00pm ET, featuring commentary from the chief executive officers of Accelsius, AeroFlexx, and Refinity. The press release is furnished as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure.

• ·Event filed under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
• ·Company address: 6900 Tavistock Lakes Blvd, Suite 400, Orlando, Florida 32827.
• ·Telephone: (321) 209-6787.

15-04-2026

Hingham Institution for Savings filed its 13F-HR report disclosing holdings in 15 securities with a total market value of $113161857 as of March 31, 2026. Notable positions include 308612 shares of Chain Bridge Bancorp Inc Cl A (sole voting authority), 119450 shares of Alphabet Inc Cap Stk Cl A, 65150 shares of Visa Inc Com Cl A, and 41450 shares of Berkshire Hathaway Inc Del Cl B New. All holdings are reported as sole discretionary with no shared or other voting authority.

• ·Filing date: April 15, 2026
• ·Report period end: March 31, 2026
• ·All positions held with sole voting authority; no shared discretion or other managers reported

15-04-2026

Strawberry Fields REIT, Inc. disclosed various risk factors in an 8-K filing, highlighting heavy concentration risks with 86.8% of annualized base rent from 15 master leases affiliated with executives Moishe Gubin and Michael Blisko, and 97.7% derived from skilled nursing facilities. The company also faces substantial indebtedness of $752.1 million as of December 31, 2025, along with vulnerabilities from related-party leases not negotiated at arm's length, potential tenant defaults, labor shortages, inflation, and dependence on key personnel. These factors could materially adversely affect operations, financial condition, and distributions to stockholders.

• ·Leases with related parties not negotiated on arm’s-length basis and subject to conflicts of interest policies requiring audit committee approval.
• ·Tenants under master leases are affiliates, increasing risk of widespread defaults from single adverse events like regulatory exclusions from Medicare/Medicaid.
• ·Portfolio lacks diversification, with tenant base limited to skilled nursing operators dependent on government reimbursements.

15-04-2026

R.H. Dinel Investment Counsel, Inc. filed its 13F-HR report disclosing $123613204 in total holdings across 40 securities as of March 31, 2026, all held on a sole discretionary basis with no shared voting authority or other managers reported. Top positions include Microsoft Corp ($16866796, 45565 shares), Starbucks Corp ($5883823, 65675 shares), and Adobe Systems Incorporated ($5032971, 20705 shares). No period-over-period changes or performance metrics are provided in the filing.

• ·All 40 holdings reported as SH SOLE with 0 SH PRN (put/call), 0 SH SVRD, and 0 OTHER.
• ·Filing effective date: April 15, 2026; date as of change: April 14, 2026.
• ·Business address: 11661 San Vicente Blvd., Suite 400, Los Angeles, CA 90049.

15-04-2026

Galera Therapeutics, Inc. (GRTX) and Obsidian Therapeutics announced a definitive all-stock merger agreement, forming a combined company to operate as Obsidian Therapeutics, Inc. (proposed ticker: OBX) focused on advancing Obsidian’s engineered TIL therapies like OBX-115, supported by a $350 million concurrent private placement providing runway into 2H 2028 through key 2027 milestones. However, pre-closing Galera stockholders will own only ~1.8% of the combined company (subject to net cash adjustments), with Obsidian holders at ~53.2% and PIPE investors at ~45%, alongside CVRs entitling them to 95% of future milestones from Galera’s October 2025 Biossil.ai asset sale.

• ·Transaction expected to close by Q3 2026, subject to stockholder approvals, SEC registration effectiveness, and customary conditions.
• ·OBX-115: Phase 2 trial for advanced melanoma; Phase 1 for NSCLC; granted FDA Fast Track and RMAT designations for unresectable/metastatic melanoma resistant to checkpoint inhibitors.
• ·Key milestones: NSCLC Phase 1 data (1H 2027); melanoma registration-enabling topline data (year-end 2027).
• ·CVR for Galera stockholders: up to 10 years on Biossil.ai milestones.
• ·Private placement investors include Balyasny Asset Management, Caligan Partners LP, Eventide Asset Management, and others.

15-04-2026

M2i Global, Inc. (MTWO), a Nevada-based emerging growth company and smaller reporting company, filed a 10-KT transition report for the short fiscal period from December 1, 2025, to December 31, 2025, covering business operations in critical minerals and materials essential for U.S. national defense and economic security. The company aims to develop a diversified portfolio of projects to address U.S. supply chain vulnerabilities amid foreign export bans on minerals like antimony, tungsten, and tantalum. As of March 31, 2026, 760,182,298 common shares were outstanding, with an aggregate market value of non-affiliate common equity at $64,912,936.

• ·Registrant is a non-accelerated filer, smaller reporting company, and emerging growth company.
• ·No securities registered pursuant to Section 12(b) or 12(g) of the Exchange Act.
• ·Principal executive offices at 885 Tahoe Blvd., Incline Village, NV 89451.
• ·I.R.S. Employer Identification No.: 37-1904036.

15-04-2026

World Acceptance Corporation (NASDAQ: WRLD) appointed Janet Matricciani as interim President and CEO effective April 13, 2026, following the resignation of R. Chad Prashad as President, CEO, and board member to pursue other opportunities. The board, chaired by Ken Bramlett, Jr., praised Ms. Matricciani's prior CEO experience and initiated a search for a permanent replacement. No immediate financial impacts were disclosed.

• ·Founded in 1962 and headquartered in Greenville, South Carolina.
• ·Fiscal year ended March 31, 2025 (reference to latest 10-K).
• ·Website: www.loansbyworld.com.

15-04-2026

Brookfield Asset Management Ltd. (BAM) announced on April 14, 2026, an offering of US$550 million principal amount of 4.832% senior notes due 2031 and US$450 million re-opening of its existing 5.298% senior notes due 2036. The re-opening will increase the aggregate principal amount of the 2036 notes series from the previously issued US$400 million (on November 18, 2025) to US$850 million. Preliminary and final Canadian term sheets for the notes are filed as Exhibits 99.1 and 99.2.

• ·Filing submitted on April 15, 2026, pursuant to Items 8.01 and 9.01 of Form 8-K.
• ·Notes offerings incorporate term sheets into BAM’s Registration Statement on Form F-10 (File No. 333-293350).

15-04-2026

Lunai Bioworks Inc. (LNAI) is seeking shareholder approval for a reverse stock split of its Common Stock at a ratio between 1-for-3 and 1-for-30 to increase the per-share trading price above $1.00 and avoid Nasdaq delisting after a prior 1-for-10 split in September 2025 and a February 2026 delisting notice, with 36,271,119 shares outstanding as of the Record Date and a closing price of $0.37 on April 10, 2026. While the Board believes this will enhance marketability and listing compliance, risks include no guarantee of sustained price increase, potential reduced liquidity, and increased authorized unissued shares leading to future dilution. A second proposal allows adjournment to solicit more votes if needed.

• ·Prior 1-for-10 reverse stock split effected on September 30, 2025.
• ·Nasdaq delisting notice received February 6, 2026; hearing held March 26, 2026, with delisting stayed pending decision.
• ·Board adopted resolutions on April 2, 2026; filing date April 15, 2026.
• ·Par value remains $0.0001 per share; trading symbol 'LNAI' expected to continue.
• ·Fractional shares rounded up to next whole share, no cash payments.
• ·No current plans to issue additional authorized shares beyond general corporate purposes.

15-04-2026

Soluna Holdings, Inc. filed an S-1 registration statement on April 14, 2026, to register the resale of 26,512,815 shares of common stock by the Selling Holder under a Standby Equity Purchase Agreement (SEPA) entered on August 12, 2024, which allows the company to sell up to $25 million in shares at its discretion. As of April 1, 2026, 3,000,000 shares have already been issued under the SEPA, with current outstanding common stock at 113,181,690 shares, potentially diluting to 139,694,505 shares if fully utilized. The filing highlights the company's Renewable Computing™ model for data centers colocated with renewable energy, and it qualifies as a smaller reporting company with reduced disclosure obligations.

• ·SEPA effective date: August 12, 2024
• ·Stockholder approval for issuances exceeding 19.99% obtained on November 15, 2024
• ·Hypothetical issuance at $0.71/share: up to 27,617,515 shares (Option 1) or 27,332,799 shares (Option 2)
• ·Nasdaq symbol: SLNH
• ·Smaller reporting company thresholds: public float < $250M or annual revenues < $100M
• ·Principal office: 325 Washington Avenue Extension, Albany, NY 12205

15-04-2026

Pasqal Holding SAS CEO Wasiq Bokhari presented at the 'Pasqal Thoughts 2026: Defining Quantum Now' event, highlighting achievements including experimentally verified quantum simulations of real-world materials (unachievable classically) and solving differential equations using neutral atom logical qubits. The company announced plans to go public via a business combination with Bleichroeder Acquisition Corp. II, targeting a Nasdaq listing in H2 2026, supported by €340M ($400M) in new funding comprising €170M ($200M) private financing and €170M ($200M) committed convertible financing. Pasqal emphasized deployments of quantum processors in standard data centers and HPC environments, with no reported setbacks.

• ·Pasqal quantum processors deployed in high-performance computing (HPC) data centers and accessible via cloud.
• ·In-house manufacturing capabilities for QPUs operational in standard data centers without cryogenics.
• ·Nasdaq listing planned for H2 2026, followed by potential Euronext Paris listing.
• ·Quantum Advantage demonstrations in materials science targeted by end of Q1 2026.
• ·Part of IBM Quantum Network with integration for hybrid HPC/cloud environments.

15-04-2026

Juncture Wealth Strategies, LLC filed its 13F-HR on April 15, 2026, disclosing 134 equity positions with a total market value of $299,189,080 as of March 31, 2026. Top holdings by value include Vanguard Index Fds Large Cap Etf ($60,689,958), Schwab Strategic Tr Us Brd Mkt Etf ($31,798,707), and Dimensional Etf Trust Us Mktwide Value ($17,706,695), with all positions reported as solely held. No changes from prior periods or performance metrics are disclosed in the filing.

• ·Filing covers period ending March 31, 2026
• ·All holdings reported as SH SOLE (sole voting authority)

15-04-2026

Tradewinds Universal reported revenue of $133,222 for the year ended December 31, 2025, down 22% YoY from $171,596 in 2024, while gross profit declined 11% to $133,222 due to zero COGS in 2025 versus $21,645 previously. Operating expenses surged 368% to $1,026,099, driven by $886,105 in consulting and $60,695 in marketing, resulting in a net loss widening to $892,877 from $115,743. However, the company raised equity through share issuances totaling approximately $1.17M (including $894,700 for services and $200,000 for assets), boosting total assets to $307,333 from $31,510 and cash to $16,638 from $210.

• ·New auditor Fruci & Associates II, PLLC (PCAOB #05525) served since 2025.
• ·Intangible assets increased to $216,500 (net) from $31,300, including AI App at $190,000.
• ·No debt or accounts payable; zero current liabilities both years.
• ·Net cash used in operating activities increased to $57,572 from $28,003.
• ·On June 8, 2025, issued 1,500,000 shares for services to a non-affiliated entity.

15-04-2026

Edenor's 2025 tariff category analysis shows Residential users (46% of electricity sales) declined 1.6% YoY in energy sales value (GWh), while Industrial users (15%) decreased 2.7% YoY; Small Commercial (8%) grew a flat 0.1% and Medium Commercial (7%) a flat 0.8%. The filing highlights risks including potential inability to collect government-financed energy sales, cybersecurity threats, and capital movement restrictions affecting ADS holders. Operational updates include hardware renewals for the SCADA system and printer/plotter inventory.

• ·Risk of inability to collect energy sales for neighborhoods financed by Argentine Government, Province of Buenos Aires, and Autonomous City of Buenos Aires.
• ·Cybersecurity risks from IT interruptions or cyber-attacks could impact business, financial condition, operations, and cash flows.
• ·Capital outflow restrictions from Argentina may impair ADS holders' ability to receive dividends, distributions, or sale proceeds.

15-04-2026

Veea Inc. reported net sales of $222,018 for the year ended December 31, 2025, up 57% from $141,760 in 2024, with gross profit increasing to $152,037 from $58,470 due to a 16% decline in cost of goods sold. Operating expenses fell sharply to $18,987,372 from $84,136,020, driven by significant reductions in product development (-76%), sales and marketing (-57%), general and administrative (-34%), and transaction costs (from $55.0M to $25K), narrowing the net loss to $6,660,038 from $47,547,768 (-86%). However, revenue remains insignificant, losses persist with anticipation of continued significant losses, and there are no plans for cash dividends.

• ·No current plans to pay cash dividends on common stock.
• ·Net cash used in investing activities: $247,337 (2025) vs. $265,445 (2024).
• ·UK R&D Tax Credit: $1,202,554 (2025, -4% YoY).
• ·Depreciation and amortization increased 131% YoY to $632,479.
• ·Company does not currently incur advertising costs.

15-04-2026

Tilray Brands, Inc. entered into private debt-for-equity exchange transactions between April 1, 2026, and April 8, 2026, issuing 1,879,696 shares of common stock in exchange for $12 million aggregate principal amount of its 5.20% Convertible Senior Notes due June 15, 2027. The shares were issued without registration under the Securities Act, relying on the Section 3(a)(9) exemption as exchanges with existing security holders without commissions.

• ·Transactions with unrelated parties.
• ·Exchange occurred between April 1, 2026, and April 8, 2026.

15-04-2026

CTT Pharmaceutical Holdings, Inc. (CTTH), a developer of fast-dissolving oral drug delivery strips for pharmaceuticals, nutraceuticals, and nicotine, filed an S-1/A amendment on April 15, 2026, registering 6,250,000 shares of common stock for resale by RH2 Equity Partners under an Equity Line of Credit Agreement dated September 8, 2025, potentially providing up to $10 million in proceeds to the company. Current common stock outstanding is 58,712,232 shares, increasing to 64,962,232 post-offering, with shares trading on OTCQB at $0.065 as of April 8, 2026. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Filing effective as soon as practicable after SEC declaration.
• ·Common stock listed on OTCQB under symbol CTTH.
• ·Principal executive offices: 1646 W Snow Avenue Suite 138, Tampa, FL 33606.
• ·Company classified as non-accelerated filer, smaller reporting company, and emerging growth company.

15-04-2026

Tradewinds Capital Management, LLC filed its 13F-HR on April 15, 2026, disclosing holdings as of March 31, 2026, across 719 positions with a total portfolio value of $503,547,089. Top holdings include Apple Inc. COM (16,422 shares valued at $4,167,655), Amazon.com Inc. COM (13,870 shares valued at $2,888,705), Exxon Mobil Corp. COM (13,545 shares valued at $2,298,064), Alphabet Inc. CAP STK CL C (6,911 shares valued at $1,982,555), and Berkshire Hathaway Inc. DEL CL B NEW (2,311 shares valued at $1,107,432). The portfolio features a diversified mix of equities, ETFs, and other securities held solely.

• ·Filer CIK: 0001616026
• ·SEC File Number: 028-16264
• ·Business address: 2211 Rimland Drive, Suite 401, Bellingham, WA 98226
• ·All holdings reported with sole voting and disposition power (SH SOLE)

15-04-2026

On April 14, 2026, Mike Krieger resigned from the Board of Directors of Figma, Inc. effective immediately, with no disagreements on operations, policies, or practices. The Board expressed thanks for his service and contributions. No other changes or impacts were disclosed.

• ·Filing submitted on April 15, 2026, reporting event of April 14, 2026.
• ·Figma, Inc. is an emerging growth company.

15-04-2026

15-04-2026

Capital Insight Partners, LLC filed a 13F-HR report on April 15, 2026, disclosing its equity holdings as of March 31, 2026. The filing contains metadata and filer details but no specific holdings or quantitative data on positions. It was signed by Susan C. Anastasiadis, Member.

• ·Central Index Key (CIK): 0001664385
• ·SEC File Number: 028-17100
• ·Business Address: 7328 E. DEER VALLEY RD. STE 105, SCOTTSDALE, AZ 85255
• ·Conformed Period of Report: 03-31-2026

15-04-2026

15-04-2026

HighRoad Wealth Advisors, LLC disclosed 37 equity holdings totaling $102384313 as of March 31, 2026, in its 13F-HR filing submitted April 15, 2026. The portfolio is heavily weighted toward ETFs, with the top position in Vanguard Index Fds S&P 500 ETF SHS (CUSIP 922908363) valued at $30665583 (51319 shares), followed by SPDR Series Trust State Street SPD (CUSIP 78468R663) at $10750956 and Invesco QQQ TR Unit Ser 1 (CUSIP 46090E103) at $9454440. All 37 positions are held solely with full voting authority and no reported puts, calls, or other derivatives.

• ·All holdings reported with sole ownership and voting authority (SH SOLE).
• ·No put/call positions or other investment discretion reported.
• ·Adviser CIK: 0002079807, SEC file number: 028-25984.
• ·Business address: 170 S 2nd St Suite 201, Coos Bay, OR 97420.
• ·Report as-of date: March 31, 2026; filed April 15, 2026.